PSYCHIATRY, INCLUDING PSYCHEDELIC, CLINICAL TRIALS SITE OPENS IN PRIMARY CARE SETTING Novel therapies drive demand for new Paratus Clinical site
With
Megan Morrison,
Chief Executive Officer, Paratus Clinical
Professor Paul Fitzgerald,
Principal Investigator, Paratus Clinical &
Head of School of Medicine and Psychology, Australian National University
Bernadette Fitzgibbon
Director of Psychiatry Research, Paratus Clinical &
Associate Professor, Australian National University
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Melbourne | August 2025
Over the past decade, Paratus has been involved in over 200 clinical trials across 4 clinical site locations. Now a fifth site, the newly opened Melbourne site will cater to both primary care and psychiatry, specifically designed for psychedelic studies.
The new Melbourne site will be a focused on primary care studies specifically expanding access to psychiatric research, a growing area of unmet need. Australian Health Journal met with 3 recent hires brought in to support clinical trials across the organisation and in psychiatry in Melbourne.
– Megan Morrison, the recently appointed CEO of Paratus Clinical has 24 years of clinical research experience, industry knowledge and leadership, having worked across sponsor, CRO, and now site-side roles.
– Professor Paul Fitzgerald, the Director of the Australian National University School of Medicine and Psychology, provides senior academic leadership at Paratus Clinical as the Principal Investigator. Professor Fitzgerald is a renowned psychiatrist and researcher with over 25 years of experience leading clinical trials focused on psychiatric disorders. His pioneering work includes the development and evaluation of innovative treatments such as neurostimulation therapies (like transcranial magnetic stimulation) and novel pharmacological approaches. He plays a central role in trials in pharmacological-assisted psychotherapy and psychedelic compounds.
With extensive experience in conducting clinical research in psychiatry, Fitzgerald mentors the trial staff and ensures the integrity of the research protocols.
– Bernadette Fitzgibbon, the Director of Psychiatry Research at Paratus Clinical and Associate Professor at the Australian National University, has two decades experience in clinical research. She previously served as Deputy Director of the Monarch Research Institute and is affiliated with both Monash University and the Australian National University, contributing to national research efforts across psychiatry and psychology. She will collaborate closely with Professor Fitzgerald in running clinical trials in Melbourne.
Talking to Australian Health Journal, both Fitzgerald and Fitzgibbon highlight the growing need for innovative treatments in mental health, one which Paratus aims to address through a focused approach to psychiatric research.
Source: Adapted from transcript and Paratus Clinical news posts
-
Awareness campaigns and HCP Toolkits for thyroid health
In 2021, the Australian Thyroid Foundation released analysis to show, well over 1 million Australian are living with an undiagnosed thyroid disorder, including thyroid cancer, lower IQs, lifelong disability, and a causal or possible contributory factor – in the development of other neurological disorders such as ADHD and autism. Some of the challenges for diagnosis and treatment can be addressed by producing material for health care practitioners during patient presentations.
‘Recent statistics show well over 1 million Australians are living with an undiagnosed thyroid disorder, awareness and testing can prevent unwarranted outcomes for mothers and their babies’ says ATF CEO Beverley Garside OAM
The Australian Thyroid Foundation has lodged a Pre-Budget Submission for the Federal Budget 2024-25 to counter increasing misinformation on social media creating dietary deficiencies such as an increasing number of young women, who are planning pregnancy or already pregnant opting for plant based milks such almond, soy or oat milk coffee as an alternative to standard cow’s milk, which is a source of iodine and alternate milks do not include.
-
Sydney North Neighbourhood Health Hubs to approach health and welfare in holistic way
Many people struggle to access the right care at the right time, leading to gaps, delays, and confusion when navigating the health system. By fostering collaboration and integration, the Wellbeing Collaborative will support a primary care system that works better together, making it easier for individuals to receive early intervention and preventative care. By working together and in partnership, Sydney North Health Network aim to create more connected, accessible, and person-centred services that address key health challenges locally, including chronic illness, mental health, aged care, alcohol and other drugs (AOD), and suicide prevention.
-
Landmark research projects tackle critical issues in emergency healthcare
For two decades, the demand for emergency department services in Australia has outpaced population growth and wait times have increased. In 2022-2023 more than 8.8 million emergency department presentations occurred nationwide.
While demand is a contributing factor, EDs are currently being impacted by various factors across the entire health system.
The Emergency Medicine Foundation (EMF) is a non-profit organisation funding innovative Australian research that improves the way people are cared for in a medical emergency. The aim of the research is to deliver better and more effective health services to save lives and money.
